Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 15,106 $ 2,321
Accounts receivable, net of allowance for doubtful accounts of $275 and $25, respectively 7,239 10,197
Other current assets 3,751 3,851
Total current assets 26,096 16,369
Property and equipment, net 7,249 6,814
Other intangible assets, net 31,439 33,501
Goodwill 8,433 8,433
Operating lease right of use assets 5,172 3,892
Other long-term assets 42 42
Total assets 78,431 69,051
Current liabilities:    
Accounts payable 3,348 4,812
Accrued salary and bonus 2,247 2,341
Other accrued expenses 9,737 9,379
Current liabilities from discontinued operations 766 766
Total current liabilities 16,098 17,298
Contingent consideration 2,207 2,391
Operating lease liabilities, net of current portion 3,940 2,591
Line of credit 3,400 3,000
Other long-term liabilities 4,557 4,573
Total liabilities 30,202 29,853
Commitments and contingencies (Note 8)
Preferred stock, $.01 par value; 5,000,000 shares authorized, 270 Series A shares issued and outstanding 47,000 Series B shares issued and outstanding
Stockholders' equity:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,055,454 and 3,932,370 shares issued, respectively; 4,036,595 and 3,920,589 shares outstanding, respectively 402 393
Additional paid-in capital 182,980 182,514
Accumulated deficit (179,919) (168,160)
Treasury stock, at cost (18,859 and 11,781 shares, respectively) (1,770) (1,721)
Total stockholders' equity 1,693 13,026
Total liabilities and stockholders' equity 31,895 42,879
Total liabilities, preferred stock and stockholders' equity 78,431 69,051
Series A [Member]    
Current liabilities:    
Preferred stock, $.01 par value; 5,000,000 shares authorized, 270 Series A shares issued and outstanding 47,000 Series B shares issued and outstanding 26,172
Series B [Member]    
Current liabilities:    
Preferred stock, $.01 par value; 5,000,000 shares authorized, 270 Series A shares issued and outstanding 47,000 Series B shares issued and outstanding $ 46,536